Skip to Content

Alisade

Active Substance: fluticasone furoate
Common Name: fluticasone furoate
ATC Code: R01AD12
Marketing Authorisation Holder: Glaxo Group Ltd.
Active Substance: fluticasone furoate
Status: Withdrawn
Authorisation Date: 2008-10-06
Therapeutic Area: Rhinitis, Allergic, Seasonal Rhinitis, Allergic, Perennial
Pharmacotherapeutic Group: Nasal preparations

Therapeutic Indication

Adults, adolescents (12 years and over) and children (6 - 11 years). Alisade is indicated for the treatment of the symptoms of allergic rhinitis.

The marketing authorisation for Alisade has lapsed because it has not been marketed in the European Union in the three years following the granting of the authorisation.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide